Page 5 - CANNABIS NEWS FLORIDA DECEMBER 2021
P. 5

Cannabis News Florida                                                                          cannabisnewsflorida.com                                                           December 2021                         32





















                              844-PUR-WELL (787-9355).
                                                     For more information, please visit www.purwell.com or call

                                                                             5. Any money-back guarantees?
                                                                             4. Where is the farm or where does the hemp supply come from?
                                                                             3. What is the shelf life or expiration date on the products?
                                                                                 potency test? Was the product tested for mold, mycotoxins, etc.?
                                                                             2. Do you have 3rd party lab tests for your products beyond the cannabinoid
                                                                             1. Are your products made from organic hemp?
                                                                             Here is a short list of those questions, he notes:
                                                                               purchasing any company's CBD products,” he says.
                                                                               so it is up to each consumer to know the basic questions they should be asking before
                                                                             “There are more inferior CBD products on the market than there are effective ones,
                                                                               cautious when making a purchase.
                                                                             Hoffman stresses that all CBD is not created equal and that consumers need to be
                                                                               our full panel 3rd party lab testing for all our products.”
                                                                               they want to know that the product is safe for their patients to use. That ties in with
                                                                               with drug-on-drug interaction, and any potential adverse drug reactions (ADRs), and
                                                                               going to get ‘high’ when using our products,” says Hoffman. “They are also concerned
                                                                               Continued from page 36


                                                                               Whole Plant Relief

                                                                               General Health and Wellness Through

                                                                               Back Cover Story:  PūrWell: Promoting


                                                           trol of those businesses.
                                                                                                                expertise, having previously served as CEO of Coolbrands®
                                                           ate future will continue to participate in the direction and con-
                                                                                                               Serruya is a seasoned cannabis investor with extensive retail
                                                           Boston LLC and MME Newton Retail LLC, and for the immedi-
                                                                                                                tional strategic opportunities.
                                                                                                                flexibility to execute on its growth priorities and explore addi-
                                                         Lynch will continue to serve as the Manager of MedMen
                                                           profitability in 2022."
                                                                                                                with Gotham Green Partners, LLC, provides MedMen with the
                                                           against our aggressive growth plans and achieve company-wide
                                                                                                                MedMen that were originally held by certain funds affiliated
                                                           Michael and the Board will identify the right CEO to execute
                                                                                                                ity of the outstanding senior secured convertible notes of
                                                                                                                States. This, together with Tilray , Inc.’s acquisition of the major-
                                                           MedMen 2.0, which is now in growth mode. I am confident
                                                                                                                opportunities across the United
                                               MedMen through its transformation into
                                                                                                                fy and accelerate further growth
                                              Lynch said, "It has been an honor to lead
                                                                       Michael Serruya
                                               ally ."
                                                                                                                operations in key markets and identi-
                                               across the United States, Canada and internation-
                                                                                                                Serruya Private Equity to expand its
                                               and consumer experience in order to expand it
                                                                                                                investment in the Company by
                                               to leverage the strength of the MedMen brand
                                                                                                                August 2021 as part of a $100 million
                                                                                                               Serruya joined MedMen’s board in
                                               taking this Company to the next level as we seek
                                                                                                                turnaround.
                                               MedMen 2.0," said Serruya. "Our focus now is
                                               well positioned for accelerated growth as
                                                                                                                oversaw the Company’s operational
                                                                                                                who held the position since 2020 and
                                               disciplined turnaround plan, which has left us
                                                                                                                ing Chairman and CEO Tom Lynch,
                                               the past 20 months as he’s led a successful and
                                                                                                                immediately . Serruya succeeds outgo-
                                              "We want to thank Tom for his leadership over
                                                                                                                Chairman and Interim CEO, effective
                                              - ADVERTISEMENT -
                                               Creamery®, Taco Time® and Blimpie Subs®).
                                                                                                                appointed Michael Serruya as
                                                                                                                announced its Board of Directors has
                                               to global QSR brands including Cold Stone
                                                                                                                across the United States, today
                                               Godiva® Ice Cream) and Kahala Brands® (home
                                                                                                                cannabis retailer with operations
                                               Watchers®, Eskimo Pie®, Tropicana® and
                                                                                                               MedMen Enterprises Inc., a premier
                                               (then home to CPG brands including Weight
                                                                                         as Chairman and Interim CEO
                                                                                               MedMen Announces Michael Serruya
                                                                     TM
                            AROUND
   1   2   3   4   5   6   7   8   9   10